1.08
-0.01(-0.92%)
Currency In USD
| Previous Close | 1.09 |
| Open | 1.12 |
| Day High | 1.13 |
| Day Low | 1.05 |
| 52-Week High | 1.28 |
| 52-Week Low | 0.28 |
| Volume | 334,334 |
| Average Volume | 788,033 |
| Market Cap | 32.2M |
| PE | -1.04 |
| EPS | -1.04 |
| Moving Average 50 Days | 0.82 |
| Moving Average 200 Days | 0.6 |
| Change | -0.01 |
If you invested $1000 in Cosmos Health Inc. (COSM) 10 years ago, it would be worth $5,346.53 as of September 28, 2025 at a share price of $1.08. Whereas If you bought $1000 worth of Cosmos Health Inc. (COSM) shares 5 years ago, it would be worth $3.02B as of September 28, 2025 at a share price of $1.08.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cosmos Health Expands Order Book with Contract Manufacturing Agreement with Medical Pharmaquality S.A. for 3 Million MYCOFAGYL® Pessaries Annually
GlobeNewswire Inc.
Sep 25, 2025 12:00 PM GMT
CHICAGO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its wholly owned subsidiary, Cana Laboratories S.A.
Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue
GlobeNewswire Inc.
Sep 22, 2025 12:00 PM GMT
CHICAGO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the commencement of its U.S. operations with the launch o
Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units
GlobeNewswire Inc.
Sep 11, 2025 12:00 PM GMT
CHICAGO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its wholly owned subsidiary, Sky Pharm SA, signed a